A human study to evaluate safety and effective dose of Phellinus baumii extract complex on platelet aggregation response and blood flow in healthy subjects given a dietary lipid challenge: a randomized, double-blind, placebo-controlled, cross-over study

Ewha Womans University0 个研究点目标入组 56 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•BMI > 35kg/m2
•body weight fluctuation of 10% or more in the past 8weeks
•excessive activity
•takes hormone therapy (female)
•excessive smoker
•drinking alcohol more than 140g/week
•platelet function disorder
•taking anti-platelet medication (aspirin, non-steroidal anti-inflammatory drugs)
•cardiovascular or haematological disorders, insulin resistance, diagnosed non-insulin dependent diabetes
•disease (Cardiovascular disease, heart failure, myocardial infarction, cerebrovascular disease, arteriosclerosis, diabetes, thyroid abnormality, ulcer, gastric bleeding, infectious diseases, systemic inflammatory diseases, acute inflammation, malignancy, renal disease, renal function, liver disease, lung disease, blood coagulopathy)
•take oriental medicine or other medicine during test period continuously
•subjects who have hypersensitivity about test material
•take fuctional foods continuously in the 4 weeks
•participate other human study in the 12 weeks
•pregnat woman or lactating woman
•subjects who unsuiable about this study

发起方